Health

How is one Chinese biotechnology group succeeding in supporting the earliest stage of new drug discovery when global pharmaceutical companies have given up? Dr Jun Mao, founder and chairwoman of Viva Ventures, explains how it leverages its in-house expertise to invest in hundreds of biotech startups in the $20 trillion global pharmaceutical and biotechnology market.

How is one Chinese biotechnology group succeeding in supporting the earliest stage of new drug discovery when global pharmaceutical companies have given up? Dr Jun Mao, founder and chairwoman of Viva Ventures, explains how it leverages its in-house expertise to invest in hundreds of biotech startups in the $20 trillion global pharmaceutical and biotechnology market.

The management of risk is essential to the human experience. For families who may be targets for attempted fraud, extortion or, in extreme cases, personal security risks such as kidnapping, mitigation begins with consciousness of the risks and having the right underlying protections in place.

The management of risk is essential to the human experience. For families who may be targets for attempted fraud, extortion or, in extreme cases, personal security risks such as kidnapping, mitigation begins with consciousness of the risks and having the right underlying protections in place.